These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11934258)

  • 41. Kininases and vascular responses to kinins.
    Babiuk C; Marceau F; St-Pierre S; Regoli D
    Eur J Pharmacol; 1982 Feb; 78(2):167-74. PubMed ID: 6122586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
    Wiernas TK; Griffin BW; Sharif NA
    Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
    Carmona AK; Juliano L
    Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of bradykinin-induced contraction of the guinea-pig gallbladder in vitro.
    Cabrini DA; Silva AM; Calixto JB
    Br J Pharmacol; 1995 Apr; 114(8):1549-56. PubMed ID: 7599922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
    Corrêa CR; Calixto JB
    Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptors for kinins: from classical pharmacology to molecular biology.
    Regoli D; Pheng LH; Allogho SN; Nguyen-Le XK; Gobeil F
    Immunopharmacology; 1996 Jun; 33(1-3):116-22. PubMed ID: 8856128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P.
    Ahmad S; Ward PE
    Proc Soc Exp Biol Med; 1992 May; 200(1):115-21. PubMed ID: 1315058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New agonist and antagonist analogues of bradykinin.
    Barabé J; Caranikas S; D'Orléans-Juste P; Regoli D
    Can J Physiol Pharmacol; 1984 Jun; 62(6):627-9. PubMed ID: 6146395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity studies of B1 receptor-related peptides. Antagonists.
    Gobeil F; Neugebauer W; Filteau C; Jukic D; Allogho SN; Pheng LH; Nguyen-Le XK; Blouin D; Regoli D
    Hypertension; 1996 Nov; 28(5):833-9. PubMed ID: 8901831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin-converting enzyme, bradykinin, angiotensin, and cerebral vessel reactivity.
    Whalley ET; Wahl M; Sampaio CA
    Hypertension; 1983; 5(6 Pt 3):V34-7. PubMed ID: 6317557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the mechanism of action of bradykinin on human basilar artery in vitro.
    Whalley ET; Amure YO; Lye RH
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):433-7. PubMed ID: 3037391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of ligand-induced regulation of kinin receptor expression in the rabbit.
    Sabourin T; Guay K; Houle S; Bouthillier J; Bachvarov DR; Adam A; Marceau F
    Br J Pharmacol; 2001 Aug; 133(7):1154-62. PubMed ID: 11487527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium.
    Rump LC; Berlit T; Schwertfeger E; Beyersdorf F; Schollmeyer P; Bohmann C
    J Hypertens; 1997 Nov; 15(11):1263-70. PubMed ID: 9383175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.
    Campbell DJ
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):903-11. PubMed ID: 8846511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New highly potent bradykinin B2 receptor antagonists.
    Regoli D; Rhaleb NE; Tousignant C; Rouissi N; Nantel F; Jukic D; Drapeau G
    Agents Actions; 1991 Sep; 34(1-2):138-41. PubMed ID: 1665287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin.
    Tio RA; Heiligers JP; de Langen CD; van Gilst WH; König W; Saxena PR; Wesseling H
    J Hypertens Suppl; 1989 Dec; 7(6):S296-7. PubMed ID: 2561143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effects of kinins on angiotensin I conversion in the local circulation.
    Sasaguri M; Ideishi M; Ikeda M; Arakawa K
    Clin Exp Hypertens A; 1990; 12(4):551-69. PubMed ID: 2196127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.